Successful de novo conversion from [psi−] to [PSI+] Saccharomyces cerevisiae  by Koellhoffer, Edward C. et al.
Sunday, March 1, 2009 91apeptide. This peptide can be present as monomers with soluble disordered
structure, which change conformation into partially folded intermediates and
further assemble to form dimers, trimers, oligomers, protofibrils and larger fi-
brils. Earlier studies have suggested that neurotoxicity of the disease lies not in
the insoluble fibrils but in the formation of soluble oligomers, which impair and
alter neurotransmision. Thus, the solution conformation of Ab is of significant
interest for understanding the molecular mechanism of Ab fibrillogenesis. In
the present study we have investigated the process of fibril formation in the
25 residue Ab(10-35) which has a similar fibril structure as Ab40 and Ab42.
In addition, Ab(10-35) contains the central hydrophobic cluster (residues 17-
21) suspected to initiate folding.
We have employed fluorescence, circular dichroism (CD) and time-dependent
UVRR spectroscopic methods to explore the fibril formation process in vitro.
Thioflavin-T induced fluorescence and CD studies indicate a conformational
transition from an unfolded to b-sheet structure. UVRR studies conducted
with 215 nm and 230 nm excitation facilitate characterization of the two phe-
nylalanine and one tyrosine residues in the peptide, respectively. It is observed
that formation of soluble Ab oligomers is accompanied by a decrease in the in-
tensities of the Phe vibrational mode, v8a (1606 cm-1) and the Tyr vibrational
mode, v8a (1617 cm-1) over a 150 min incubation period. These results indicate
that fibril formation proceeds via phenylalanine and tyrosine p-stacking inter-
actions, which stabilize parallel b-sheets and reduce solvent exposure. Based on
these results we have proposed a probable mechanism of fibril formation in
Ab(10-35).
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Amyloid beta (Ab) is 4 kDa peptide which is thought to form aggregates such as
oligomers and fibrils, and to cause Alzheimer disease (AD). Recently, it has
been suggested that soluble Ab oligomers are the causative agent of AD since
such oligomers are more cytotoxic than fibrils. It was also suggested that Ab
oligomers affect not only cell death but also early stage of cell dysfunction
and cause memory loss.
However, the mechanism how soluble oligomers are produced is still un-
known. In this study, we analyzed formation of Ab oligomers in vitro at a sin-
gle molecule level using photon counting histogram (PCH)(Chen, Y. et al.
(1999) Biophys. J. 77, 553-67; Terada, N. et al. (2007) Biophys. J. 92,
2162-71.). Using PCH method, the number of protomers in oligomers and con-
centrations are obtained from histograms of photons from fluorescent mole-
cules. Combination of a conforcal optics and a photon counting sensor enables
us to catch the fluorescence from molecules diffusing through the conforcal
volume at PCH. The concentration distribution of oligomers can be calculated
from histograms.
Fluorescent intensity of fluorescein-labeled Ab monomer (FL-Ab) was evalu-
ated using PCH. After 30 min incubation of FL-Ab in buffer solution, dimer
fraction was successfully observed with PCH, assuming that fluorescent inten-
sity is in proportion to the number of protomers in oligomers. Detailed analysis
of formation of Ab oligomers such as amyloid-beta derived diffusible ligands
(ADDLs) using these techniques is in progress.
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The misfolding of certain proteins into b-sheets and their ensuing aggrega-
tion into fibrous networks that accumulate to form insoluble plaques has
been found to be related to several neurodegenerative disorders such as Alz-
heimer’s Disease, Huntington’s Disease, and the spongiform encephalopa-
thies. The structural details of these protein aggregates and their mecha-
nisms of aggregation, however, have not yet been fully understood. This
research analyzes the structure and misfolding processes of a fragment of
the b-amyloid (Ab) polypeptide comprising residues 16 - 22 (KLVFFAE).
Ab 16-22 aggregates by forming intermolecular antiparallel b-sheets; lami-
nation of these sheets results in formation of fibrils or micro-crystallite
structures. We have probed the conformation of Ab 16-22 as a function
of concentration, temperature, and solvent using circular dichroism (CD)
and infrared (IR) spectroscopies. The data show that, as the concentration
increases, the conformation of Ab 16-22 changes from a random coil to
a b-sheet to higher-order structures; these higher order structures have
a unique CD signature, with enhancement of the positive feature at ~200
nm. Addition of hexafluoroisopropanol (HFIP) disrupts the b-sheet structure,and the kinetics of this change can be observed spectroscopically. Overall,
these observations allow us to construct a model of the mechanism of Ab
16-22 aggregation.
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The in vivo aggregation of many different polypeptides into b-sheet-rich am-
yloid fibers is associated with a range of diseases. The mechanism of aggre-
gation for many of these proteins is still unknown; small polypeptides are
useful models for exploring this process by both physical and computational
methods. H1, a peptide derived from residues 109-122 of the Syrian hamster
prion peptide (Ac-MKHMAGAAAAGAVV-NH2) forms antiparallel b-sheet
aggregates in solution. As determined by isotope-edited infrared (IR) spec-
troscopy, the H1 b-sheets have three overhanging residues at the N-terminus,
with residue 117 aligned in all strands (1). The A117G mutant, however, ex-
ists nearly entirely as monomer as a result of backbone flexibility and the
inability to align across residue 117 (2). In this study, the results of mixing
wild-type H1 and A117G were monitored by Fourier Transform infrared
spectroscopy (FTIR). Regardless of their relative concentrations, combining
H1 and A117G resulted in the spontaneous, irreversible conversion of
A117G from its unordered form to b-sheet by a mechanism in which the
H1 peptides are proposed to serve as a nucleating template. Isotope-edited
IR studies suggest that the b-sheet formed after mixing H1 and A117G is
composed of alternating strands from each peptide variant. This process oc-
curs spontaneously over time, and its rate is accelerated with increasing tem-
perature. This work suggests a model for the templating of an unordered
polypeptide into a b-sheet fibril.
(1) Silva, R.A.G.D., W. Barber-Armstrong and Decatur, S.M. (2003) J. Am.
Chem. Soc. 125: 13674.
(2) Petty, S.A., Adalsteinsson, T., and Decatur, S.M. (2005) Biochemistry 44: 4720.
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Prion protein disorders, such as transmissible spongiform encephalopathies
(TSEs) and Creutzfeldt-Jacob Disease (CJD), are caused by amyloid aggrega-
tion within a cell. The amyloid aggregates are proteinaceous, rich in b-pleated
sheets, and characterized by protease resistance. Saccharomyces cerevisiae nat-
urally expresses Sup35, a protein that spontaneously aggregates and forms in-
tracellular amyloid fibers. Sup35 exhibits multiple prion states: [psi], strong
[PSIþ], and weak [PSIþ] phenotypes. Prior studies have induced multiple
[PSIþ] phenotypes by using in vitro aggregation reactions of bacterially ex-
pressed Sup35NM at varying temperatures and then in some instances trans-
forming S. cerevisiae with these aggregate ‘‘seeds.’’ By implementing a unique
color assay, the different phenotypes may be visually identified as red, pink,
and white colonies for [psi], weak [PSIþ], and strong [PSIþ], respectively.
Here our research focused on inducing strong [PSIþ] and weak [PSIþ] prion
states from [psi] cells without the use of preformed prion seeds. We have
found that exposure of mid-exponential phase cultures of [psi] 74-D694 yeast
to a 4C environment for an extended period of time induced de novo an array
of [PSIþ] phenotypes. Our current focus is on purifying the amyloids of these
phenotypic variants and analyzing their secondary structure and conformations
using a variety of techniques, including transmission electron microscopy and
X-ray diffraction. We will also compare the structural data from the de novo
amyloid with those of amyloid fibers that formed in vitro from bacterially-ex-
pressed Sup35NM.
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Residues 109-122 of the Syrian hamster prion peptide (Ac-MKHMAGAA
AAGAVV-NH2) make up a conserved amyloidogenic portion of a protein
associated with several neurodegenerative diseases. In previous studies using
Fourier Transform infrared spectroscopy (FTIR) and isotope-edited infrared
spectroscopy, H1 has been determined to form antiparallel b-sheets in solution
with three overhanging residues at the N-terminus and alignment of residues
117 in all strands (1, 2). Some amyloidogenic proteins form antiparallel b-sheet
